Aktuellt
SENASTE
Redeye endorses SenzaGen’s new grant from RIFM, valued at SEK3.0m. We argue that the order should be considered large and highlight SenzaGen’s solid relationship with RIFM. Our sales estimates remain untouched, and we reiterate our base case.
LÄS MER
